Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease leukemia
Phenotype C0026946|fungal disease
Sentences 4
PubMedID- 21482489 Voriconazole is effective as secondary antifungal prophylaxis in leukemia patients with prior pulmonary fungal disease: case series and review of literature.
PubMedID- 26366612 Posaconazole vs fluconazole or itraconazole for prevention of invasive fungal diseases in patients with acute myeloid leukemia or myelodysplastic syndrome: a cost-effectiveness analysis in an asian teaching hospital.
PubMedID- 25689528 Aim: we retrospectively analyzed 141 acute leukemia patients with unclassified invasive fungal disease episodes during chemotherapy to determine the optimum duration of antifungal treatment.
PubMedID- 24644249 In preventing invasive fungal disease (ifd) in patients with acute myelogenous leukemia (aml) or myelodysplastic syndrome (mds), clinical trials demonstrated efficacy of posaconazole over fluconazole and itraconazole.

Page: 1